Trial reportNutrition journal2025
Effects of the MIND diet on cardiometabolic health and novel anthropometric measures in women with type 2 diabetes and insomnia: a randomized controlled trial.
Trial report in Nutrition journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Women with diabetes are at an elevated risk for cardiovascular disease (CVD), and insomnia exacerbates these risks, highlighting the urgent need for effective interventions that improve cardiometabolic health and reduce mortality in this population. This study aimed to evaluate the effects of the MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet on cardiometabolic health and novel anthropometric indices in 44 women, aged 30 to 65, with type 2 diabetes and insomnia. In this randomized controlled trial, participants were assigned to either the MIND low-calorie diet (MLCD) or a standard low-calorie diet (LCD) for 12 weeks. Outcomes assessed at baseline and after 12 weeks included lipid profiles, markers of glycemic control, blood pressure, and anthropometric measures. The results revealed that the MIND diet significantly improved fasting blood sugar (FBS) (-19.31, 95% CI: -38.43 to -0.19), total cholesterol (TC) (-24.49, 95% CI: -35.05 to -13.93), low-density lipoprotein cholesterol (LDL-c) (-20.31, 95% CI: -32.67 to -7.95), systolic blood pressure (SBP) (-7.75, 95% CI: -12.46 to -3.05), diastolic blood pressure (DBP) (-2.51, 95% CI: -4.28 to -0.73), waist circumference (WC) (-1.64, 95% CI: -2.71 to -0.57), waist-to-hip ratio (WHR) (-0.02, 95% CI: -0.04 to -0.002), waist-to-height ratio (WHtR) (-0.01, 95% CI: -0.02 to -0.004), and body roundness index (BRI) (-0.26, 95% CI: -0.45 to -0.07), compared to the control group (p < 0.05). These findings suggest that the MIND diet could be a feasible and beneficial dietary approach to improving cardiometabolic outcomes in women with type 2 diabetes and insomnia, although further research is needed to confirm these results.Trial registrationTrial registration number: IRCT20181111041611N8 on 07/08/2023.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.